Landing Page_Pipeline Clinical Trials.png

Our Pipeline

At Roche, our researchers are tirelessly developing our oncology and non-malignant hematology pipeline to fuel new discoveries that will transform lives of patients living with cancer and difficult-to-treat blood disorders. Clinical trials are carefully and rigorously designed, reviewed and evaluated to assess the efficacy and safety of new cancer and non-malignant hematology therapies, that enables us to lead the delivery of new treatments to patients as fast as possible.

Information on the pipeline is provided for the purpose of scientific medical discussion only. The mentioned compounds are investigational and may not have been approved in some, or any of the entities they are being investigated for.